相关实验视频
Updated: May 15, 2026

13:51
The MultiBac Protein Complex Production Platform at the EMBL
Published on: July 11, 2013
细菌细菌的多层次工程用于高水平的功能扩展的细胞外生产
Fang Luan1,2, Yangyang Li1,2, Xianhao Xu1,2
1Science Center for Future Foods, Jiangnan University, Wuxi, China.
Biotechnology journal
|March 4, 2026
概括
这项研究设计了Bacillus subtilis的高水平扩张生产,实现了农业生物技术和生物加工应用的创纪录产量. 微生物扩散素证明增强了纤维素降解,提高了生物质分解效率.
科学领域:
- 生物技术是生物技术.
- 微生物工程 微生物工程
- 蛋白质生产 蛋白质生产
背景情况:
- 扩素对于植物细胞生长和生物质解构至关重要.
- 植物衍生膨因其少量和不一致性而面临工业生产的局限性.
研究的目的:
- 开发一种微生物系统,用于高水平的细胞外扩散素的产生.
- 为了工程 Bacillus subtilis 增强生产 BsEXLX1 和 LeEXP2 的扩散素.
主要方法:
- 细菌细菌的多层次工程,包括促进体选,RBS和信号优化.
- 在5L生物反应器中进行养批量培养,以扩大规模.
- 评估纤维素降解中的扩散功能.
主要成果:
- 在摇瓶中实现了 232.3 mg/L BsEXLX1 和 15.6 mg/L LeEXP2 的细胞外产量.
- 在5L生物反应器中达到1.3g/L BsEXLX1和43.7 mg/L LeEXP2,是B. subtilis.中报告的最高水平.
- 微生物扩散素对纤维素降解有协同作用,增强了糖的释放.
结论:
- 建立了一个可扩展的B. subtilis平台,用于高层次的功能扩展生产.
- 证明了B. subtilis.中有效的细胞外蛋白质生产的可转移框架.
- 微生物扩散素对生物处理和生物质解构具有前景.
相关概念视频
Bioreactor Controls-III
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
Scale-Up Processes
The scale-up of microbial fermentation processes is essential in industrial biotechnology, allowing the transition from laboratory-scale experiments to commercial-scale production while aiming to maintain product yield and quality. This process requires meticulous adjustment of equipment design, process parameters, and contamination control strategies to accommodate increasing culture volumes.At the laboratory scale, cultures are typically maintained in 1 to 10-liter glass or autoclavable...
Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
Production of Biopesticides
Biopesticides offer a sustainable alternative to chemical pesticides, utilizing microbial agents to control agricultural pests. Bacillus thuringiensis (Bt) is a widely employed bacterium known for its potent insecticidal activity. Bt biopesticides are favored for their specificity to insect pests, minimal environmental impact, and natural degradability.Mechanism of Bt Toxin Action Bt produces insecticidal crystal (Cry) proteins during its sporulation phase. These proteins form parasporal...

